BioSpace News Archive

Genetown

Albireo to Receive More than $55M(1) in Nondilutive Cash Payments

At December 31, 2017, Albireo had approximately $53.5 million in cash and cash equivalents.

January 19, 2018
·
6 min read
Drug Development

Enzychem Lifesciences Announces the FDA Orphan Drug Designation Granted to EC-18 on Acute Radiation Syndrome (ARS)

The company is now qualified to receive benefits throughout its orphan drug development program.

January 19, 2018
·
3 min read
Business

Sanofi Appoints Dominique Carouge Executive Vice President Head of Business Transformation and Member of the Executive Committee

He has served as Deputy CFO and Head of Finance Operations and Group Controlling since January 1st, 2016.

January 19, 2018
·
3 min read
Drug Development

AVEO Oncology Announces Presentation of Data from Phase Ib/II Study of Tivozanib in Patients with Advanced Hepatocellular Carcinoma

There were no significant changes in HBV or HCV viral load during study treatment. Tivozanib was generally well tolerated at 1.0 mg daily, with adverse events consistent with those observed in previous tivozanib trials.

January 19, 2018
·
7 min read
New 2D Superresolution Mode for ZEISS Airyscan Delivers 120 Nanometer Lateral Resolution

At Neuroscience 2017, a new imaging mode for the ZEISS LSM 8 family with Airyscan has been introduced.

January 19, 2018
·
3 min read
BioForest

Magno-Humphries Laboratories Issues Voluntary Nationwide Recall of Basic Drugs Brand of Senna Laxative Due to Mislabeling

Magno-Humphries Laboratories, Inc., is voluntarily recalling one lot of Basic Drugs Brand of Senna Laxative tablets, 8.6mg Sennosides to the consumer level due to a customer complaint that their bottle labeled as Senna Laxative actually contained Basic Drugs Brand of Naproxen Sodium 220mg.

January 19, 2018
·
3 min read
Business

Hanger Reports Full Year 2016 and 2015 Results

The Annual Report on Form 10-K contains information pertaining to the Company’s interim quarterly, year-to-date and annual results for 2016 and 2015.

January 19, 2018
·
67 min read
Pharm Country

PAVmed Announces Pricing of Firm Commitment Common Stock Offering

PAVmed announced the pricing of its previously announced underwritten public offering of 2,415,278 shares of its common stock at a price to the public of $1.80 per share. In addition,

January 19, 2018
·
4 min read
Biotech Beach

San Diego’s Obalon Preps $35M Offering

The offering is expected to close on or about January 23, 2018, subject to customary closing conditions.

January 19, 2018
·
2 min read
BioMidwest

KMR Group Release: Fast Site Contract Timelines in New App

The application is based on Phase II and III clinical trial contract milestones from leading biopharma companies and CROs.

January 19, 2018
·
2 min read